KathleenM(Aras)Aras-RichardMD

PubMed

• 1 citations
  Predictive Significance of an Optimized Panel for Basal-like Breast Cancer: Results from the Canadian Cancer Trials Group MA.5 and MA.12 Phase III Clinical Trials.
  Karama Asleh, Dongsheng Tu, Dongxia Gao, Vivien H.C. Bramwell, Mark Levine, Kathleen I. Pritchard, Lois E. Shepherd, Torsten O. Nielsen> ;Clinical Cancer Research. 2021 Oct 6
• 10 citations
  Updated results from the international phase III ALTTO trial (BIG 2-06/Alliance N063D).
  Alvaro Moreno-Aspitia, Eileen Holmes, Christian Jackisch, Evandro de Azambuja, Frances M. Boyle, David W. Hillman, Larissa A. Korde, Debora Fumagalli, Miguel Izquierdo...> ;European Journal of Cancer. 2021 May 1
• 5 citations
  The association between endocrine therapy use and dementia among post-menopausal women treated for early-stage breast cancer in Ontario, Canada.
  Phillip S. Blanchette, Melody Lam, Britney Le, Lucie Richard, Salimah Z. Shariff, Kathleen I. Pritchard, Jacques Raphael, Theodore A. Vandenberg, Ricardo Fernandes, Da...> ;Journal of Geriatric Oncology. 2020 Sep 1
• 52 citations
  Patient-Reported Cognitive Impairment Among Women With Early Breast Cancer Randomly Assigned to Endocrine Therapy Alone Versus Chemoendocrine Therapy: Results From TAI...
  Lynne I. Wagner, Robert Gray, Joseph A. Sparano, Timothy J. Whelan, Sofia F. Garcia, Betina Yanez, Amye J. Tevaarwerk, Ruth C. Carlos, Kathy S. Albain, John A. Olson, ...> ;Journal of Clinical Oncology. 2020 Apr 9
• 33 citations
  Early Modulation of Circulating MicroRNAs Levels in HER2-Positive Breast Cancer Patients Treated with Trastuzumab-Based Neoadjuvant Therapy.
  Serena Di Cosimo, Valentina Appierto, Sara Pizzamiglio, Marco Silvestri, José Baselga, Martine Piccart, Jens Huober, Miguel Izquierdo, Lorena de la Peña, Florentine Hi...> ;International Journal of Molecular Sciences. 2020 Feb 18
• 40 citations
  Incidence of Brain Metastases in Nonmetastatic and Metastatic Breast Cancer: Is There a Role for Screening?
  Adam S Komorowski, Ellen Warner, Helen Mackay, Arjun Sahgal, Kathleen I. Pritchard, Katarzyna J. Jerzak> ;Clinical Breast Cancer. 2020 Feb 1
• 2 citations
  Association between BMI, vitamin D, and estrogen levels in postmenopausal women using adjuvant letrozole: a prospective study.
  Mitchell J Elliott, Marguerite Ennis, Kathleen I Pritchard, Carol Townsley, Dave Warr, Christine Elser, Eitan Amir, Philippe L Bedard, Lakshmi Rao, Vuk Stambolic, Srik...> ;NPJ Breast Cancer. 2020 Jan 1
• 19 citations
  The LISA randomized trial of a weight loss intervention in postmenopausal breast cancer.
  Pamela J Goodwin, Roanne J Segal, Michael Vallis, Jennifer A Ligibel, Gregory R Pond, André Robidoux, Brian Findlay, Julie R Gralow, Som D Mukherjee, Mark Levine, Kath...> ;NPJ Breast Cancer. 2020 Jan 1
• 15 citations
  Factors associated with endocrine therapy adherence among post-menopausal women treated for early-stage breast cancer in Ontario, Canada
  Phillip S. Blanchette, Melody Lam, Lucie Richard, Britney Allen, Salimah Z. Shariff, Theodore A. Vandenberg, Kathleen I. Pritchard, Kelvin K. W. Chan, Alexander V. Lou...> ;Breast Cancer Research and Treatment. 2020 Jan 1
• Identifying research priorities in the treatment of patients with early breast cancer: from the patient perspective.
  Kathleen I. Pritchard> ;Breast. 2019 Nov 1
• 36 citations
  Influenza Vaccine Effectiveness Among Patients With Cancer: A Population-Based Study Using Health Administrative and Laboratory Testing Data From Ontario, Canada
  Phillip S. Blanchette, Hannah Chung, Kathleen I. Pritchard, Craig C. Earle, Michael A. Campitelli, Sarah A Buchan, Kevin L Schwartz, Natasha S. Crowcroft, Jonathan B. ...> ;Journal of Clinical Oncology. 2019 Aug 29
• 11 citations
  A priori prediction of breast tumour response to chemotherapy using quantitative ultrasound imaging and artificial neural networks.
  Hadi Tadayyon, Mehrdad J. Gangeh, Lakshmanan Sannachi, Maureen E. Trudeau, Kathleen I. Pritchard, Sonal Ghandi, Andrea Eisen, Nicole Look-Hong, Claire M. B. Holloway, ...> ;Oncotarget. 2019 Jun 11
• 283 citations
  Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer.
  Joseph A. Sparano, Robert Gray, Peter M. Ravdin, Della F. Makower, Kathleen I. Pritchard, Kathy S. Albain, Daniel F. Hayes, Charles E. Geyer, Elizabeth Claire Dees, Ma...> ;The New England Journal of Medicine. 2019 Jun 3
• 5 citations
  A meta-analysis of clinical benefit rates for fulvestrant 500 mg vs. alternative endocrine therapies for hormone receptor-positive advanced breast cancer
  John F.R. Robertson, Zefei Jiang, Angelo Di Leo, Shinji Ohno, Kathleen I. Pritchard, Matthew J. Ellis, Ian Bradbury, Christine M. Pierce Campbell> ;Breast Cancer. 2019 May 11
• 15 citations
  Cognitive effects of adjuvant endocrine therapy in older women treated for early-stage breast cancer: a 1-year longitudinal study
  Emily A. Underwood, Katarzyna J. Jerzak, Gerald Lebovic, Paula A. Rochon, Christine Elser, Kathleen I. Pritchard, Mary C. Tierney> ;Supportive Care in Cancer. 2019 Jan 4
• 59 citations
  Adjuvant Anti-HER2 Therapy, Treatment-Related Amenorrhea, and Survival in Premenopausal HER2-Positive Early Breast Cancer Patients
  Matteo Lambertini, Christine Campbell, José Bines, Larissa A. Korde, Miguel Izquierdo, Debora Fumagalli, Lucia Del Mastro, Michail Ignatiadis, Kathleen I. Pritchard, A...> ;Journal of the National Cancer Institute. 2019 Jan 1
• 4 citations
  Bone-Targeted Therapy in Early Breast Cancer.
  Katarzyna J. Jerzak, Jacques Raphael, Danielle N Desautels, Phillip S. Blanchette, Ivan Tyono, Kathleen I. Pritchard> ;Oncology. 2018 Nov 15
• 17 citations
  Effects of Celecoxib and Low-dose Aspirin on Outcomes in Adjuvant Aromatase Inhibitor-Treated Patients: CCTG MA.27.
  Kathrin Strasser-Weippl, M. Higgins, Judith-Anne W. Chapman, James N. Ingle, George W. Sledge, George Thomas Budd, Matthew J. Ellis, Kathleen I. Pritchard, Mark Clemon...> ;Journal of the National Cancer Institute. 2018 Sep 1
• 12 citations
  Thyroid hormone receptor beta-1 expression in early breast cancer: a validation study
  K J Jerzak, Jessica G. Cockburn, Sukhbinder Dhesy-Thind, Gregory R. Pond, Kathleen I. Pritchard, Sharon Nofech-Mozes, Ping Sun, Steven A. Narod, Anita Bane> ;Breast Cancer Research and Treatment. 2018 Jun 18
• 22 citations
  Preliminary Investigation of Focused Ultrasound-Facilitated Drug Delivery for the Treatment of Leptomeningeal Metastases.
  Meaghan A. O'Reilly, Tricia Chinnery, My-Linh Yee, Sheng-Kai Wu, Kullervo Hynynen, Robert S. Kerbel, Gregory J. Czarnota, Kathleen I. Pritchard, Arjun Sahgal> ;Scientific Reports. 2018 Jun 13
• 1248 citations
  Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer
  Joseph A. Sparano, Robert Gray, Della F. Makower, Kathleen I. Pritchard, Kathy S. Albain, Daniel F. Hayes, Charles E. Geyer, Elizabeth Claire Dees, Matthew P. Goetz, J...> ;The New England Journal of Medicine. 2018 Jun 3
• 50 citations
  Cognitive sequelae of endocrine therapy in women treated for breast cancer: a meta-analysis
  E A Underwood, Paula A. Rochon, Rahim Moineddin, Philip E. Lee, Wei Wu, Kathleen I. Pritchard, Mary C. Tierney> ;Breast Cancer Research and Treatment. 2018 Apr 1
• 3 citations
  An update on treatment for post-menopausal metastatic breast cancer in elderly patients.
  Ines B Menjak, Katarzyna J. Jerzak, Danielle N Desautels, Kathleen I. Pritchard> ;Expert Opinion on Pharmacotherapy. 2018 Mar 30
• 12 citations
  Factors influencing survival among patients with HER2-positive metastatic breast cancer treated with trastuzumab.
  P. S. Blanchette, Danielle N Desautels, Gregory R. Pond, Jms Bartlett, Sharon Nofech-Mozes, Martin J. Yaffe, Kathleen I. Pritchard> ;Breast Cancer Research and Treatment. 2018 Mar 8
• 15 citations
  Phosphoinositide 3-kinase inhibitors in advanced breast cancer: A systematic review and meta-analysis.
  Jacques Raphael, Danielle N Desautels, Kathleen I. Pritchard, Ekaterina Petkova, Prakeshkumar S Shah> ;European Journal of Cancer. 2018 Mar 1
• Join now to see all